IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 178 filers reported holding IMPAX LABORATORIES INC in Q4 2014. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $1,177,000 | -87.3% | 49,661 | -84.5% | 1.45% | +141.2% |
Q2 2016 | $9,238,000 | +39.8% | 320,552 | +55.4% | 0.60% | +50.4% |
Q1 2016 | $6,606,000 | -16.2% | 206,313 | +11.9% | 0.40% | -13.8% |
Q4 2015 | $7,881,000 | +36.3% | 184,317 | +12.2% | 0.46% | +62.5% |
Q3 2015 | $5,782,000 | -31.9% | 164,218 | -11.2% | 0.28% | -22.8% |
Q2 2015 | $8,496,000 | -14.0% | 185,032 | -12.2% | 0.37% | -7.3% |
Q1 2015 | $9,874,000 | -16.4% | 210,687 | -43.5% | 0.40% | -16.9% |
Q4 2014 | $11,807,000 | -45.8% | 372,696 | -59.4% | 0.48% | -40.3% |
Q3 2014 | $21,783,000 | +199.1% | 918,733 | +278.4% | 0.80% | +225.1% |
Q2 2014 | $7,282,000 | +4.9% | 242,814 | -7.6% | 0.25% | +42.0% |
Q1 2014 | $6,944,000 | -4.7% | 262,841 | -9.3% | 0.17% | -3.9% |
Q4 2013 | $7,288,000 | -47.2% | 289,898 | -57.0% | 0.18% | -50.8% |
Q3 2013 | $13,803,000 | – | 674,323 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aravt Global | 2,670,000 | $125,143,000 | 9.40% |
Krensavage Asset Management, LLC | 410,944 | $19,261,000 | 8.77% |
BANBURY PARTNERS LLC | 292,660 | $13,717,000 | 8.70% |
Slate Path Capital LP | 1,935,000 | $90,693,000 | 5.72% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 285,000 | $13,358,000 | 4.69% |
Orbimed Advisors | 6,678,000 | $312,998,000 | 2.67% |
Pennant Capital Management, LLC | 2,025,000 | $94,912,000 | 1.78% |
Iguana Healthcare Management, LLC | 75,000 | $3,515,000 | 1.48% |
Leonard Capital Management, Inc. | 89,235 | $4,182,000 | 1.44% |
HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $11,718,000 | 1.23% |